RECENT NEWS

Time is running out to secure best-price tickets for IBMS Congress, with the Premium Early Discount rates coming to an end on 30 April.

Beckman Coulter Life Sciences is leading the way to help laboratories prepare for critical upgrades to comply with the new In Vitro Diagnostic Medical Devices Regulation (IVDR), and to clear up confusion for laboratories that will soon be governed by IVDR.

Xyall and Indica Labs have entered into a global strategic partnership designed to bridge the gap between histology and molecular pathology. It unites Xyall’s unique automated tissue dissection solutions with Indica Labs’ AI-powered, diagnostic digital pathology platform.

NHS laboratories across Greater Manchester have begun to go live with technology that will transform how pathologists across the region collaborate; helping to improve timely diagnosis of cancers and other illnesses.

Oxford Nanopore Technologies the company delivering a new generation of nanopore-based molecular sensing technology, and in vitro diagnostics company bioMérieux have announced that they have teamed up to improve health outcomes globally by exploring selected opportunities to bring nanopore sequencing to the infectious disease diagnostics market.

PreOmics has launched a BeatBox-based formalin-fixed, paraffin wax-embedded (FFPE) workflow, which simplifies, speeds up and standardises FFPE sample preparation for deep, unbiased tissue proteomics by subsequent protein digestion and nanoLC-MS/MS analysis.

The NHS Health Research Authority has launched its new Artificial Intelligence and Digital Regulations Service website, which aims to clearly set out the information and guidance that developers and adopters need to follow to develop safe, innovative technologies in health and social care.

Fujifilm Irvine Scientific has expanded its BalanCD CHO Media Platform portfolio with the addition of two new, chemically defined growth media - BalanCD CHO Perfusion and BalanCD CHO DG44.

The Validair technical sales team has accepted the top award for business growth and commercial performance from contamination control world leader TSI Inc. at its Channel Partner conference in Spain.

Enalees, a biotech company producing rapid molecular diagnostic tests for the veterinary profession, has announced the official opening of its new proteomics development and production laboratory at the Genopole cluster site (Greater Paris region, France) for production of recombinant proteins and to strengthen R&D for its rapid diagnostic kits to support veterinary professionals.

The NHS has launched a new testing programme to diagnose thousands of people with a genetic condition that increases the chance of developing cancer. Lynch syndrome is an inherited condition that increases the risk of certain cancers, including bowel, ovarian and pancreatic, which can be identified with a genomic test.

The SHOT team has announced its first webinar of 2023 covering a UK Transfusion Laboratory Collaborative (UKTLC) overview, highlights from the UKTLC survey results, latest standards, and available resources.

Genomics England has confirmed its partnership with the inaugural Genomics and Precision Medicine Expo, taking place on 23-24 May 2023 at ExCeL London.

INTEGRA Biosciences has introduced its ‘School of Pipetting’, a new collection of educational presentations for all pipetting queries. The new resource covers a selection of key topics, including basic pipetting techniques, pipette maintenance guidelines and health advice for the prevention of repetitive strain injuries.

Oncology therapeutics company Mosaic Therapeutics has announced the close of its $28 million series A funding round. The company has also appointed former Novartis Oncology SVP Brian Gladsden as CEO.

The first NHS Trust of the PathLAKE Plus consortium has signed an individual contract to adopt Aiforia PD-L1 AI model for lung cancer in clinical diagnostics. The duration of the contract is three years, with a possible three-year extension.

Capitainer has launched a fully automated sample handler that enables large-scale screening and diagnostics using the company’s self-sampling products. This technology effectively cuts down on the number of manual steps and reduces the time that laboratory staff spend preparing Capitainer samples for analysis.

MUJN Diagnostics – a subsidiary of PanGenomic Health – is partnering with Portland, Oregon-based medical diagnostic device company Hemex Health to develop a diagnostics system, which can be used to support patients being treated with alternative therapies for brain health.

The IBMS Congress continues to provide as many options to attend its highly popular programmes as it is possible to cram into a comprehensive four-day programme.

PHC and NovaScan have announced the launch of a collaboration through which they will seek to explore the feasibility of MarginScan, an investigational ex vivo medical device that will seek to support clinicians in detecting non-melanoma skin cancers (NMSC).